Peter Virsik - 05 Jan 2024 Form 4 Insider Report for ESSA Pharma Inc. (EPIX)

Role: Chief Operating Officer
Signature: /s/ Peter Virsik
Issuer symbol: EPIX
Transactions as of: 05 Jan 2024
Transactions value $: -$4,271
Form type: 4
Filing time: 08 Jan 2024, 20:06:58 UTC
Previous filing: 01 Nov 2022
Next filing: 17 Jan 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EPIX	Common Shares	Sale	-$4.27K	-699	-4.75%	$6.11	14K	05 Jan 2024	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id	Content
F1	The amount reflects the sale of shares pursuant to Mr. Virsik's 10b5-1 trading plan. The Rule 10b5-1 trading plan was entered into on August 31, 2023.